What This Document Is
This document represents a team problem assignment – specifically, “Team Problem 2” – for Drexel University’s Economics of Health Care Systems (ECON 240) course. It focuses on applying probability concepts and economic evaluation techniques to healthcare scenarios, specifically around drug effectiveness and cost-benefit analysis. The assignment requires students to work through calculations related to probabilities, expected values, and cost-utility ratios.
Why This Document Matters
This assignment is designed for students enrolled in ECON 240 who are learning to quantitatively assess healthcare interventions. It’s likely used as a practical exercise to reinforce concepts covered in lectures and readings about health economics, pharmaceutical pricing, and decision-making under uncertainty. Students completing this assignment will demonstrate their ability to apply economic principles to real-world healthcare challenges.
Common Limitations or Challenges
This document provides a set of problems to *apply* economic and probabilistic reasoning, but it does not offer foundational instruction on these concepts. Students are expected to already understand the underlying principles of probability, expected value, and cost-utility analysis. It also focuses on a specific set of scenarios and may not cover the full breadth of applications within health economics.
What This Document Provides
The full document includes four distinct questions. Question 1 tests understanding of basic probability principles. Question 2 involves calculating key metrics like failure rates, total costs, expected value benefits, and quality-adjusted benefits for two different drugs. Question 3 focuses on determining a cost-utility ratio between the two drugs. Finally, Question 4 asks students to communicate the trade-offs of each drug to a patient in lay terms.
This preview *does not* include the detailed calculations or the student’s complete explanations for each question. It also does not provide the answers to the problems.